Want to see AU:CTQ full AI Analyst Report?
Top Page
Careteq Ltd.
(Sydney:CTQ)
Select Model
Select Model
Rating:45Neutral
Price Target:
AU$0.01
▲(10.00% Upside)
Action:Reiterated
Date:08/01/26
The score is driven primarily by improving operating performance toward break-even, but it is held back by elevated balance-sheet risk (higher leverage) and ongoing cash burn. Technicals provide only modest support via price holding above key moving averages, while valuation remains challenging due to negative earnings and no dividend yield data.
Positive Factors
Revenue Scaling
The company has materially grown top-line over several years to 7.6m in 2025, showing product-market traction and commercial execution in healthcare IT. Durable revenue expansion supports future operating leverage and provides a foundation for sustained profitability if growth continues.
Negative Factors
Rising Leverage
Leverage rose sharply as debt jumped, compressing balance-sheet flexibility. Higher debt-to-equity increases financing risk and interest obligations, making the company more vulnerable to profit volatility and reducing its ability to invest organically without raising external capital.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Scaling
The company has materially grown top-line over several years to 7.6m in 2025, showing product-market traction and commercial execution in healthcare IT. Durable revenue expansion supports future operating leverage and provides a foundation for sustained profitability if growth continues.
Read all positive factors
Careteq Ltd. (CTQ) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$9.53M
Dividend YieldN/A
Average Volume (3M)1.68M
Price to Earnings (P/E)―
Beta (1Y)<0.01
Revenue Growth-20.21%
EPS Growth-66.67%
CountryAU
Employees686
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding733,118,700
10 Day Avg. Volume2,453,882
30 Day Avg. Volume1,675,213
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)1.19
Price to Sales (P/S)0.63
P/FCF Ratio-2.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Careteq Ltd. Business Overview & Revenue Model
Company Description
Careteq Limited engages in medication management and clinical governance for health, aged, and home care sectors in Australia. The company provides healthcare safety and clinical services. Careteq Limited was incorporated in 2016 and is based in M...
Careteq Ltd. Financial Statement Overview
Summary
Income Statement
42
Neutral
Balance Sheet
35
Negative
Cash Flow
28
Negative
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.08M | 7.62M | 7.23M | 4.98M | 4.43M |
| Gross Profit | 5.79M | 1.50M | 6.74M | -2.44M | 4.14M |
| EBITDA | 13.95K | 275.62K | -826.62K | -2.65M | -5.90M |
| Net Income | -398.12K | -72.20K | -2.67M | -4.33M | -5.25M |
Balance Sheet | |||||
| Total Assets | 3.78M | 5.94M | 6.82M | 7.57M | 8.02M |
| Cash, Cash Equivalents and Short-Term Investments | 3.19M | 1.05M | 1.25M | 1.85M | 4.50M |
| Total Debt | 47.56K | 2.37M | 192.98K | 961.96K | 0.00 |
| Total Liabilities | 549.17K | 4.42M | 3.30M | 4.02M | 1.72M |
| Stockholders Equity | 3.23M | 1.52M | 1.97M | 2.14M | 6.30M |
Cash Flow | |||||
| Free Cash Flow | -1.56M | -804.93K | -2.59M | -3.42M | -4.54M |
| Operating Cash Flow | -1.50M | -732.06K | -1.30M | -2.53M | -4.52M |
| Investing Cash Flow | 3.92M | 119.16K | -570.80K | -799.63K | -256.83K |
| Financing Cash Flow | -278.85K | 400.96K | 1.27M | 687.55K | 8.81M |
Careteq Ltd. Technical Analysis
Negative
0.01
Price Trends
0.01
Negative
0.01
Negative
Market Momentum
>-0.01
Negative
46.30
Neutral
-50.00
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CTQ, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 46.30 is Neutral, neither overbought nor oversold. The STOCH value of -50.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:CTQ.
Careteq Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | AU$130.33M | 57.65 | 2.53% | ― | 26.61% | 41.67% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | AU$167.84M | -9.44 | -203.69% | ― | -1.53% | 28.29% | |
49 Neutral | AU$33.96M | -1.83 | -58.13% | ― | 2.08% | -195.31% | |
47 Neutral | AU$20.03M | ― | -578.72% | ― | 113.42% | 29.17% | |
45 Neutral | AU$9.53M | -10.83 | 11.00% | ― | -20.21% | -66.67% | |
43 Neutral | AU$20.06M | -2.42 | -1688.04% | ― | 11.45% | 0.69% |
* Healthcare Sector Average
AU:CTQ
Careteq Ltd.
0.01
<0.01
8.33%
AU:ONE
Oneview Healthcare Chess Depository Interests repr 1
0.20
-0.02
-11.11%
AU:BMT
Beamtree Holdings Ltd
0.11
-0.11
-50.00%
AU:ALC
Alcidion Group Limited
0.10
<0.01
7.78%
AU:ICR
InteliCare Holdings Limited
0.03
0.01
68.75%
AU:PCK
PainChek Ltd
0.11
-0.32
-75.00%
Careteq Ltd. Corporate Events
Careteq strengthens balance sheet and pivots to HMR Referrals platform
Jul 30, 2026
Careteq has completed a transformational June quarter, divesting Embedded Health Solutions, executing a two-tranche capital raising, and repaying all borrowings, which collectively lifted its cash balance to $3.2 million and removed all debt and c...
Careteq secures ASX backing as it pivots to HMR Referrals growth
Jul 22, 2026
Careteq has secured continued quotation of its securities on the ASX after the exchange confirmed the company retains sufficient operations and financial strength following the sale of its Embedded Health Solutions subsidiary. The confirmation sta...
Careteq Issues 35.6 Million New Shares in Routine Capital Management Move
Jun 3, 2026
Careteq Limited has issued 35,567,808 fully paid ordinary shares at $0.01 per share, expanding its share base via a placement conducted without a prospectus under the Corporations Act. The company confirmed it is compliant with its financial repor...
Careteq clears debt as Tony G converts notes into equity
Jun 3, 2026
Careteq Limited has strengthened its capital structure after strategic investor Antanas Guoga, a prominent European technology investor and former Member of the European Parliament, converted 355,678 unquoted convertible notes into 35,567,808 full...
Careteq adds seasoned director Leonard Math to board as it pursues AI healthtech growth
Jun 3, 2026
Careteq Limited has strengthened its board with the appointment of experienced company director and Chartered Accountant Leonard Math as a Non-Executive Director, effective immediately. Math brings more than 18 years of experience across ASX-liste...
Careteq Corrects Q3 Report to Disclose $113k in Related-Party Payments
May 5, 2026
Careteq Limited has corrected its Q3 FY26 quarterly activities report after omitting required disclosure on payments to related parties. The company clarified that these payments totalled $113,000 and comprised director fees, salaries and superann...
Careteq Issues 50 Million Unlisted Options to Expand Capital Flexibility
May 4, 2026
Careteq Ltd. has notified the market of the issue of 50 million unlisted options, which are unquoted equity securities not intended to trade on the ASX. The options, recorded under a new class code yet to be confirmed, were issued on 5 May 2026 as...
Careteq Issues 401 Million New Shares to Strengthen Capital Base
May 4, 2026
Careteq Limited has issued 401,367,364 new fully paid ordinary shares at $0.005 per share, expanding its capital base through a placement conducted without a disclosure document under specific provisions of the Corporations Act. The company confir...
Careteq Seeks ASX Quotation for Over 401 Million New Shares
May 4, 2026
Careteq Ltd. has applied for quotation on the ASX of 401,367,364 ordinary fully paid shares under its CTQ ticker, with an issue date of 5 May 2026. The large volume of new quoted securities, issued as part of previously announced transactions, ind...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.